US 12,042,656 B2
Bolus stimulation in a neurostimulation device particularly useful in providing sub-perception stimulation
Que T. Doan, West Hills, CA (US); and Michael A. Moffitt, Solon, OH (US)
Assigned to Boston Scientific Neuromodulation Corporation, Valencia, CA (US)
Filed by Boston Scientific Neuromodulation Corporation, Valencia, CA (US)
Filed on Aug. 25, 2020, as Appl. No. 17/002,552.
Application 17/002,552 is a continuation in part of application No. PCT/US2020/040529, filed on Jul. 1, 2020.
Application 17/002,552 is a continuation in part of application No. 16/741,258, filed on Jan. 13, 2020, abandoned.
Application 17/002,552 is a continuation in part of application No. 16/738,786, filed on Jan. 9, 2020.
Application PCT/US2020/040529 is a continuation in part of application No. 16/657,560, filed on Oct. 18, 2019.
Application 16/657,560 is a continuation in part of application No. 16/460,640, filed on Jul. 2, 2019.
Application 16/657,560 is a continuation in part of application No. 16/460,655, filed on Jul. 2, 2019, granted, now 11,338,127.
Application 16/657,560 is a continuation in part of application No. 16/100,904, filed on Aug. 10, 2018, granted, now 10,576,282, issued on Mar. 3, 2020.
Claims priority of provisional application 62/986,365, filed on Mar. 6, 2020.
Claims priority of provisional application 62/916,958, filed on Oct. 18, 2019.
Claims priority of provisional application 62/803,330, filed on Feb. 8, 2019.
Claims priority of provisional application 62/693,543, filed on Jul. 3, 2018.
Claims priority of provisional application 62/544,656, filed on Aug. 11, 2017.
Prior Publication US 2020/0384270 A1, Dec. 10, 2020
Int. Cl. A61N 1/36 (2006.01)
CPC A61N 1/36121 (2013.01) [A61N 1/36062 (2017.08); A61N 1/36135 (2013.01); A61N 1/36175 (2013.01); A61N 1/36192 (2013.01); A61N 1/36196 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method for providing stimulation to a patient using an implantable stimulator device and an external device in communication with the implantable stimulator device, comprising:
determining stimulation parameters for the patient to address a symptom of the patient;
providing a first option on a graphical user interface of the external device to schedule scheduled boluses of stimulation for the patient, wherein each scheduled bolus comprises a first duration during which stimulation is applied to the patient in accordance with the stimulation parameters, wherein the scheduled boluses are separated by off times of a second duration when no stimulation is provided to the patient;
providing a second option on the graphical user interface of the external device to receive from the patient at a first time an input to immediately provide an additional unscheduled bolus of stimulation in accordance with the stimulation parameters; and
providing, using the implantable stimulator device, at least the scheduled boluses to neural tissue of the patient according to the schedule.